Article
Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
1 Feb 2016
Abstract excerpt
Induced pluripotent stem cells (iPSCs), which greatly circumvent the ethical issue of human embryonic stem cells (ESCs), can be induced to differentiate to dopaminergic (DA) neurons, and hence be used as a human disease model for Parkinson's disease (PD). iPSCs can be also utilised to probe the mechanism, and serve as an 'in vivo' platform for drug screening and for cell-replacement therapies. However, any...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
